Cytokines play an important role in the pathology associated with chronic inflammatory diseases.
in healthy subjects, respectively (p < 0.05). GCF IL-6 levels were markedly higher in NIDDM and adult periodontitis groups compared to the healthy controls. No correlation was found between GCF IL-6 levels and all clinical parameters. These findings suggested that GCF IL-6 levels were significantly higher in the area of inflammation and periodontal destruction locally. The high IL-6 levels in NIDDM patients might be due to different microbial flora in periodontal pockets and altered immune system. Future studies are needed to evaluate the complex interaction among IL-6 GCF levels, host response and local microbialIntroduction In recent years, the etiology of periodontal tissue breakdown is primarily attributed to the interaction of bacterial antigens and inflammatory cells resulting in the production of cytokines (1,2). IL-1 alpha, IL-1 beta, IL-6 and tumor necrosis factor alpha are proinflammatory cytokines that have been identified in gingival crevicular fluid (GCF) (3-7).
IL-6 plays a major role in the terminal differentiation of Blymphocytes to plasma cells, which are the predominant inflammatory cells in tissues involved in established and advanced periodontal disease and also enhances T cell proliferation and bone resorption (8-10). IL-6 stimulates DNA synthesis and inhibits collagen and non-collagen protein synthesis by osteoblasts, suggesting a direct role for IL-6 in regulation of bone formation (11). There is a significant correlation between tissue levels of IL-6 and the severity of the coincident inflammation (12). IL-6, synergistically with IL-1 beta, stimulates the recruitment and bone resorption by osteoclasts (4,5,10). However, the role of IL-6 in the etiology of periodontal disease remains unclear and its role in the resorption of alveolar bone to periodontitis is not specifically determined (6).
Two basic types of primary diabetes mellitus, insulin dependent (type I) and non-insulin dependent (type II), have been described. Type II, non-insulin dependent diabetes mellitus, may develop over a period of time and is often called adult-onset diabetes (13). Improved methods of assessing metabolic control in diabetics, assessing periodontal status, microbial risk factors and risk indicators in GCF, and analysis have provided new information to clarify the relationship between diabetes and periodontitis (13, 14) . A number of studies reported a higher incidence and severity of periodontal disease in diabetic patients as compared with non-diabetic subjects (15) (16) (17) .
The aim of the present investigation was to determine IL-6 GCF levels and the possible relation between periodontal status and IL-6 GCF levels in NIDDM patients with periodontitis, adult periodontitis and healthy controls. Statistical differences were found among three groups in terms of IL-6 levels (p < 0.05). No statistical differences were found between two diseased groups (p > 0.05) and statistical differences were found between healthy and diseased groups in terms of GCF volumes (p < 0.05). Table 2 showed the mean clinical parameters of entire the dentition for each group. No statistical differences were found between the two diseased groups (p > 0.05). Statistical differences were found between the healthy and diseased groups (p < 0.05).
The mean clinical parameters of sampling area for each group are given in table 3. No statistical differences were found between two diseased groups (p > 0.05). Only statistical differences were found between diseased and healthy groups (p < 0.05). Discussion Studies have reported that diabetes clearly increases the risk of severe periodontitis and the incidence of periodontal disease progression by approximately 2-3 fold (13, 22, 23) . Increased periodontal disease severity has been reported to occur in diabetic patients. A study of 254 Pima Indians with Type II diabetes mellitus found that they were 3 times more likely to have alveolar bone loss than non-diabetics (14).
Recently, many immunological and microbiological studies have been performed in diabetic patients to evaluate the relationship between diabetes and periodontal diseases (13, 15, 16, 24) . Several studies have demonstrated decreased chemotaxis, adherence and phagocytosis of pheripherial blood leukocytes in diabetic patients (15, (24) (25) (26) . A normally functioning immune system is an effective defense against any invading organisms and a defective immune system results in disease. Diabetes mellitus alters the resistance of periodontal tissues and makes them prone to invasion by microorganisms. In addition the crevicular space in patients with NIDDM may comprise a unique environment favoring an anaerobic microbial ecology (25) . It has been reported that paralleling serum glucose levels and gingival crevicular fluid glucose levels are elevated in NIDDM and may be twice that of normal subjects (27) . Zambon et al. reported that these biochemical changes and increased amounts of glucose levels in the crevicular fluid may cause the growth of facultative or anaerobic microorganisms (25) . Microbiologic and immunologic data from this previous study suggested that P. intermedia, W . recta No statistical differences were found between two diseased groups in terms of any of the parameters (p > 0.05). Statistical differences were found between diseased and healthy groups (p < 0.05). No correlation was found between GCF IL-6 levels and the clinical parameters. NS. Not significant and P. gingivalis are important in the etiology of periodontitis in adult patients with NIDDM. In the present study, GCF IL-6 levels were determined in the patients with NIDDM, adult periodontitis and healthy controls at the beginning of the treatment. After the collection of the GCF, periodontal treatment was performed but no GCF sampling was repeated after the treatment. The patients who were participants in this study were not using any hyphoglicemic agents, they were controlling their blood sugar level by diet alone. We could find no reports about the GCF IL-6 levels of the NIDDM patients with periodontitis in previous studies. However, Reinhardt et al. (4) studied the GCF levels of IL-1 beta and IL-6 in such subjects compared to premenopausal and postmenopausal estrogen treated females with moderatesevere periodontitis. Thirteen premenopausal or postmenopausal females on estrogen therapy (ES) and 13 postmenopausal females not on estrogen supplements (ED) were evaluated. IL-6 was detected more frequently in ED subjects (without estrogen therapy). In the another study, Reinhardt et al. (5) evaluated GCF IL-1 and IL-6 levels in refractory periodontitis. They found that gingival IL-1 and IL-6 production is different in response to local and systemic factors associated with periodontitis and sites from refractory patients produced significantly more IL-6 versus stable periodontitis. Geivelis et al. (3) reported the measurements of IL-6 in GCF from adults with destructive periodontal disease. Their results indicated that the amount of IL-6 in the GCF samples from diseased sites were markedly higher than the tested sites. In our study, IL-6 levels of NIDDM patients with periodontitis were higher than adult periodontitis and healthy controls (p < 0.05). Ohno et al. (16) studied the in vitro production of IL-1 , IL-6 and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus (IDDM) and non-insulin dependent diabetes mellitus patients (NIDDM). They reported that the production of IL-1 and IL-6 by monocytes was significantly lower in IDDM patients than in NIDDM patients.
In the present study, we found no correlation between the clinical parameters and IL-6 levels. This could be related to the limited area of GCF sampling. In order to eliminate the risk of contamination with saliva, GCF was only collected from the vestibular aspects of maxillary incisors.
Although similar clinical parameters were found between the NIDDM and adult periodontitis patients, the higher levels of IL-6 in NIDDM patients can be explained by different and complex host response and the local microbiological challenge. In order to better understand the role of high IL-6 levels in pathogenesis of periodontal breakdown in NIDDM patients, further studies are needed. 
